2018
2017
-
Skripova V. CRISPR/Cas9 Technique for Identification of Genes Regulating Oxaliplatin Resistance of Pancreatic Cancer Cell Line / /V. Skripova, I. Serebriiskii, Z. Abramova, R. Kiyamova // BioNanoScience. - 2017. - Vol.7, Is.1. - P.97-100.
F_CRISPR_Cas9.pdf - Skripova, V., Serebriiskii, I., Abramova, Z. et al. CRISPR/Cas9 Technique for Identification of Genes Regulating Oxaliplatin Resistance of Pancreatic Cancer Cell Line/ V. Skripova, I. Serebriiskii, Z. Abramova, I. Astsaturov, R. Kiyamova// BioNanoSci, 2017. - Vol. 7 (1), p. 97?100. doi:10.1007/s12668-016-0272-3
2016
-
Beglyarova N, Banina E, Zhou Y, Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer//Clinical Cancer Research. - 2016. - Vol.22, Is.24. - P.6153-6163.
- Beglyarova, N. Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer / N. Beglyarova, E. Banina, Y. Zhou, R. Mukhamadeeva, G. Andrianov, E. Bobrov, E. Lysenko, N. Skobeleva, L. Gabitova, D. Restifo, M. Pressman, I.G. Serebriiskii, J.P Hoffman, K. Paz, D. Behrens, V. Khazak, S.A Jablonski, L.M. Weiner, E.A. Golemis, I. Astsaturov // Clinical Cancer Research. ? 2016. ? V.22(15). doi: 10.1158/1078-0432.CCR-16-0149
2015
| Рабочий адрес: | Казань, ул. Кремлевская, д. 18, Учебное здание №02 (Восточное крыло главного корпуса университета) |
| Номер кабинета: | 104в |
| Телефон: | 2337842 |
| E-mail: | IAAscaturov@kpfu.ru |
